Karvy is bullish on Vivimed Labs and has recommended buy rating on the stock with a target of Rs 443 in its November 20, 2015 research report.
Subscribe To Our Free Newsletter |
Karvy is bullish on Vivimed Labs and has recommended buy rating on the stock with a target of Rs 443 in its November 20, 2015 research report.
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!